Cardon Children's Medical Center

4230 Articles Matching "pharma"

FDA approves Clinuvel's rare genetic disorder treatment, shares at record high

Oct 09, 2019 , Reuters
The U.S. Food and Drug Administration approved Australian drugmaker Clinuvel Pharmaceuticals Ltd's treatment for a rare inherited disorder that causes skin damage from exposure to light, sending its shares to a record high on Wednesday....
Read more

Cracks in Purdue's proposed opioid settlement as Arizona backs out

Oct 09, 2019 , Reuters
The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal," according to a court filing on Monday....
Read more

2 Ohio Counties Push Judge To Allow Opioid Case To Go Forward Despite Attorney General’s Request For Delay

Oct 05, 2019 , Kaiser Health News
Judge Dan Polster said in an order Wednesday that he did not intend to honor Ohio’s request to stop the trial, agreeing that the counties’ case doesn’t get in the way of the state’s. Also, attorneys general from 24 states say Purdue Pharma should not be allowed to pay out bonuses during its bankruptcy proceedings. News on the epidemic is from Connecticut, Massachusetts and Florida, as...
Read more

Drug Pricing Caught In Political Sniping Between Trump, Pelosi

Oct 04, 2019 , Kaiser Health News
A weekly round-up of stories related to pharmaceutical development and...
Read more

The Real Impact Of Drug Price Legislation On Biopharmaceutical R & D

Oct 03, 2019 , Forbes
A 10% budget cut in R&D across the board for the biopharmaceutical industry would be felt not just in the U.S. but around the...
Read more
Demo

How Recession Proof Is The Pharmaceutical Industry?

Oct 03, 2019 , Forbes
In the face of a possible recession, stable demand for services and technologies acts as a protective barrier for healthcare as a sector, and biopharmaceuticals, in particular. And this certainly applies to the orphan and cancer drug...
Read more

Adicet Bio raises $80 million to develop cancer cell therapies

Oct 03, 2019 , Reuters
Adicet Bio Inc, a biopharmaceutical company focused on the development of cancer therapies using gamma delta T cells, said on Wednesday it raised $80 million in private funding. "This financing will permit Adicet to continue to develop our proprietary technology, to enter the clinic in non-Hodgkin’s lymphoma and to advance our solid tumor programs," Adicet CEO Anil Singhal said....
Read more

Pharmacy Chains CVS, Walgreens, Rite Aid Remove Zantac From Store Shelves Over Cancer Concerns

Oct 02, 2019 , Kaiser Health News
The FDA is investigating the source of the contamination in the popular heartburn...
Read more

Roche's Accu-Chek recalled for sixth time, Alphabet scoops former FDA commissioner, and other digital health news briefs

Oct 02, 2019 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
Also: ResApp announces results of prospective study on obstructive sleep apnea; Cosnumer telemedicine company Hims opens pharmacy operation in Columbus,...
Read more

Why Pharmacies Are Suspending Sales Of Zantac

Oct 02, 2019 , Forbes
The flurry of announcements and actions regarding Zantac raises more questions than it answers. What is known about the relative risks associated with NDMA, whether found in water, food, or pharmaceutical products, such as...
Read more

Brick, Mortar And Pestle: Telemedicine Website Hims Will Open Its First Mail-Order Pharmacy In 2020

Oct 01, 2019 , Forbes
Hims, Inc. is set to open its first mail-order pharmacy next year in Columbus,...
Read more
Demo

Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits: WSJ

Oct 01, 2019 , Reuters
Endo International Plc, Johnson & Johnson and other drugmakers that face litigation over the opioid crisis are exploring a way to settle the cases by participating in Purdue Pharma LP's bankruptcy, the Wall Street Journal reported, citing internal documents and a person familiar with the matter....
Read more

CVS suspends sales of Zantac brand and generic heartburn drug during safety review

Sep 29, 2019 , Reuters
CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration....
Read more

Walgreens, ExpressRX To Buy Bankrupt Fred’s Pharmacy Assets For About $16.4M

Sep 28, 2019 , Kaiser Health News
Walgreens is looking to pay about $9.4M for pharmacy inventory from Fred’s, while ExpressX wants to buy nonpharmaceutical inventory and take over several leases. Other health and retail news is on Sam's Club starting a health care pilot program, rising drug prices, and Ranitidine recalls....
Read more

India's Strides Pharma halts U.S. sales of heartburn drug

Sep 28, 2019 , Reuters
India's Strides Pharma Science Ltd said on Friday it has halted sales of its heartburn drug Ranitidine in the U.S. market as it conducts tests to identify possible cancer-causing impurities in the tablets....
Read more

Federal Judge Denies Drug Companies’ Request To Remove Himself From Upcoming Ohio Opioids Trial

Sep 28, 2019 , Kaiser Health News
The drug distributors and pharmacies who are defendants in the opioid litigation argued that U.S. District Court Judge Dan Polster should remove himself from the case because of bias. Polster rejected the motion, writing: "Publicly acknowledging this human toll does not suggest I am biased; it shows that I am human." The massive lawsuit against companies like Walmart, Walgreens, CVS and Rite Aid is scheduled to start on Oct. 21 in...
Read more

U.S. judge refuses to disqualify himself from opioid litigation

Sep 27, 2019 , Reuters
The U.S. judge overseeing nationwide opioid litigation on Thursday rejected a request by several big pharmacy chains and drug distributors to disqualify himself because he appeared to be biased against them and pressed too hard for a costly settlement....
Read more

Rite Aid jumps more than 9% after reporting better-than-expected earnings

Sep 27, 2019 , CNBC Health
Rite Aid's stock surges after the pharmacy chain reports better-than-expected earnings under new CEO Heyward...
Read more

Teens may struggle to get opioid overdose drug at U.S. pharmacies

Sep 27, 2019 , Reuters
Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, a new study suggests that many pharmacies don't stock the drug or dispense it to young people who need it....
Read more

Drug Pricing: How The International Index Could Impact U.S. Consumers; Medicare Part D’s Role In Debate

Sep 27, 2019 , Kaiser Health News
A weekly round-up of stories related to pharmaceutical development and...
Read more